US treatment patterns and healthcare resource use (HCRU) for stage IVC squamous cell carcinoma of the head and neck (SCCHN).

被引：0
|
作者：
Gilden, Daniel Mordecai
Kubisiak, Joanna M.
Chace, Meredith J.
Bowman, Lee
Smyth, Emily Nash
Li, Li
Kubisiak, Emily
Gilden, David Ethan
机构：
[1] JEN Associates, Cambridge, MA USA
[2] Eli Lilly & Co, Indianapolis, IN 46285 USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2015年 / 33卷 / 15期
关键词：
D O I：
10.1200/jco.2015.33.15_suppl.e17010
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
e17010
引用
收藏
页数：1
相关论文
共 50 条
  • [31] Single Agent Irinotecan for The Treatment of Metastatic or Recurrent Squamous Carcinoma of the Head and Neck (SCCHN)
    Gilbert, J.
    Dang, T.
    Cmelak, A.
    Shyr, Y.
    Netterville, J.
    Burkey, B.
    Chung, C. H.
    Ikpeazu, E.
    Murphy, B. A.
    [J]. CLINICAL MEDICINE INSIGHTS-ONCOLOGY, 2007, 1 : 59 - 63
  • [32] Real-world treatment patterns and outcomes of patients with stage IV squamous cell carcinoma of the head and neck
    Byrne, Katherine
    Zanotti, Giovanni
    Hallworth, Pamela
    Roughley, Adam
    Martini, Jean-Francois
    Uehara, Roberto
    Iyer, Shrividya
    [J]. FUTURE ONCOLOGY, 2019, 15 (06) : 611 - 623
  • [33] Concurrent weekly paclitaxel, radiotherapy and SQ Amifostine in patients with advanced stage squamous cell carcinoma of the head and neck (SCCHN)
    Wang, R
    Latino, F
    Kagan, AR
    [J]. CANCER JOURNAL, 2002, 8 (06): : 499 - 499
  • [34] Recent results of cetuximab use in the treatment of squamous cell carcinoma of the head and neck
    Perri, Francesco
    Longo, Francesco
    Ionna, Franco
    Caponigro, Francesco
    [J]. ONCOTARGETS AND THERAPY, 2009, 2 : 243 - 250
  • [35] Toward the use of precision medicine for the treatment of head and neck squamous cell carcinoma
    Gong, Wang
    Xiao, Yandi
    Wei, Zihao
    Yuan, Yao
    Qiu, Min
    Sun, Chongkui
    Zeng, Xin
    Liang, Xinhua
    Feng, Mingye
    Chen, Qianming
    [J]. ONCOTARGET, 2017, 8 (02) : 2141 - 2152
  • [36] Analysis of chemokine and chemokine receptor expression in squamous cell carcinoma of the head and neck (SCCHN) cell lines
    Wolff, Hendrik A.
    Rolke, David
    Rave-Fraenk, Margret
    Schirmer, Markus
    Eicheler, Wolfgang
    Doerfler, Annegret
    Hille, Andrea
    Hess, Clemens F.
    Matthias, Christoph
    Roedel, Ralph M. W.
    Christiansen, Hans
    [J]. RADIATION AND ENVIRONMENTAL BIOPHYSICS, 2011, 50 (01) : 145 - 154
  • [37] TREATMENT PATTERNS AND HEALTHCARE RESOURCE UTILISATION (HCRU) IN ADVANCED HEPATOCELLULAR CARCINOMA (HCC) IN CANADA AND EUROPE
    Jaffe, D. H.
    Gill, S.
    DeCongelio, M.
    Dubell, A.
    Stetson, J.
    Wisniewski, T.
    Thompson, G. J.
    [J]. VALUE IN HEALTH, 2018, 21 : S52 - S52
  • [38] Afatinib in the treatment of head and neck squamous cell carcinoma
    Ferrarotto, Renata
    Gold, Kathryn A.
    [J]. EXPERT OPINION ON INVESTIGATIONAL DRUGS, 2014, 23 (01) : 135 - 143
  • [39] Cetuximab in the treatment of squamous cell carcinoma of the head and neck
    Specenier, Pol
    Vermorken, Jan B.
    [J]. EXPERT REVIEW OF ANTICANCER THERAPY, 2011, 11 (04) : 511 - 524
  • [40] Systemic Treatment for Squamous Cell Carcinoma of the Head and Neck
    Shetty, Aditya V.
    Wong, Deborah J.
    [J]. OTOLARYNGOLOGIC CLINICS OF NORTH AMERICA, 2017, 50 (04) : 775 - +
12345